Laser showdown: which glaucoma protocol wins?
NCT ID NCT03798223
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares different ways of performing a laser treatment called selective laser trabeculoplasty (SLT) for people with open-angle glaucoma or high eye pressure. 400 participants will receive SLT using one of several protocols, and researchers will track how much their eye pressure drops over three years. The goal is to find the safest and most effective approach to lower eye pressure and possibly delay the need for eye drops or surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Selective laser trabeculoplasty (SLT) with pilocarpine and tetracaine eye drops
What this could lead to
If successful, this could establish a standard, more effective laser procedure to lower eye pressure and reduce the need for daily eye drops in glaucoma patients.
What could go wrong
This is a mid-stage trial comparing different laser techniques, not testing a new drug. The results may show only modest differences between protocols, and long-term effectiveness varies by patient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ogonkliniken NU-sjukvarden
Uddevalla, Västra Götaland County, 45153, Sweden
-
Ogonkliniken, Sahlgrenska Universitetssjukhuset
Mölndal, Västra Götaland County, 43130, Sweden
-
Ogonkliniken, Skaraborgs Sjukhus
Skövde, Västra Götaland County, 54142, Sweden
-
Ogonkliniken, Sodra Alvsborgs Sjukhus
Borås, Västra Götaland County, 50182, Sweden